ChemAxon Software is Integrated into ChemPass’s Novel Drug Design Platform
ChemAxon and ChemPass, jointly announce that several ChemAxon software components and toolkits are incorporated into ChemPass' artificial intelligence design technology platform; and also, into...
The Great Hall of China: double digit growth at CPhI China
CPhI and P-MEC China , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event
CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China...
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
Sunovion Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) approved the New Drug Application (NDA) for Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution...
Sanofi’s BRIGHT study comparing Toujeo with insulin degludec meets primary objective
Sanofi's Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi plans...
Mylan and Aspen Announce Launch of Generic Busulfex® Injection
Mylan N.V. and its partner, Aspen announced the U.S. launch of Myleran (busulfan) Injection, 60 mg/10 mL (6 mg/mL) Single-dose Vial, a generic version...
Triphase Accelerator To Present Investigational New Drug Enabling Data For TRPH-222
Triphase Accelerator Corporation, a company dedicated to acquiring and developing novel therapeutics for the treatment of cancer, and Catalent, the leading global provider of...
EMA accepts marketing application for trastuzumab and pegfilgrastim
The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim.
The proposed biosimilars...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...